A citation-based method for searching scientific literature

Anna F Farago, Long P Le, Zongli Zheng, Alona Muzikansky, Alexander Drilon, Manish Patel, Todd M Bauer, Stephen V Liu, Sai-Hong I Ou, David Jackman, Daniel B Costa, Pratik S Multani, Gary G Li, Zachary Hornby, Edna Chow-Maneval, David Luo, Jonathan E Lim, Anthony J Iafrate, Alice T Shaw. J Thorac Oncol 2015
Times Cited: 144



Zongli Zheng, Matthew Liebers, Boryana Zhelyazkova, Yi Cao, Divya Panditi, Kerry D Lynch, Juxiang Chen, Hayley E Robinson, Hyo Sup Shim, Juliann Chmielecki, William Pao, Jeffrey A Engelman, A John Iafrate, Long Phi Le. Nat Med 2014
Times Cited: 480




List of shared articles



Times cited

High-throughput sequencing detection and ensartinib treatment of lung cancer harboring NTRK1 fusion.
Zhengbo Song, Chunwei Xu, Xingxiang Pu, Youcai Zhu, Wenxian Wang, Xingliang Li, Yanqiu Gao, Wenliang Zhu, Yunwei He, Lin Wu,[...]. Cancer Commun (Lond) 2021
0

Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers.
Tingting Jiang, Guan Wang, Yao Liu, Lu Feng, Meng Wang, Jie Liu, Yi Chen, Liang Ouyang. Acta Pharm Sin B 2021
11

Identification of NTRK gene fusions in lung adenocarcinomas in the Chinese population.
Ruiying Zhao, Feng Yao, Chan Xiang, Jikai Zhao, Zhanxian Shang, Lianying Guo, Wenjie Ding, Shengji Ma, Anbo Yu, Jinchen Shao,[...]. J Pathol Clin Res 2021
0

Mosaicism for Receptor Tyrosine Kinase Activation in a Glioblastoma Involving Both PDGFRA Amplification and NTRK2 Fusion.
Daniel J Shepherd, Tyler E Miller, Deborah A Forst, Pamela Jones, Valentina Nardi, Maria Martinez-Lage, Anat Stemmer-Rachamimov, Ramon G Gonzalez, A John Iafrate, Lauren L Ritterhouse. Oncologist 2021
0

Methods for Identifying Patients with Tropomyosin Receptor Kinase (TRK) Fusion Cancer.
Derek Wong, Stephen Yip, Poul H Sorensen. Pathol Oncol Res 2020
16

Simultaneous Detection of Gene Fusions and Base Mutations in Cancer Tissue Biopsies by Sequencing Dual Nucleic Acid Templates in Unified Reaction.
Zhengbo Song, Chunwei Xu, Yunwei He, Fugui Li, Wenxian Wang, Youcai Zhu, Yanqiu Gao, Mingfang Ji, Miao Chen, Jiajia Lai,[...]. Clin Chem 2020
10

Targeted RNA sequencing with touch imprint cytology samples for non-small cell lung cancer patients.
Katsutoshi Seto, Katsuhiro Masago, Shiro Fujita, Masataka Haneda, Yoshitsugu Horio, Toyoaki Hida, Hiroaki Kuroda, Waki Hosoda, Ken-Ichi Okubo. Thorac Cancer 2020
1

Targeting the MET-Signaling Pathway in Non-Small-Cell Lung Cancer: Evidence to Date.
Olivier Bylicki, Nicolas Paleiron, Jean-Baptiste Assié, Christos Chouaïd. Onco Targets Ther 2020
8

Molecular and clinicopathologic features of gliomas harboring NTRK fusions.
Matthew Torre, Varshini Vasudevaraja, Jonathan Serrano, Michael DeLorenzo, Seth Malinowski, Anne-Florence Blandin, Melanie Pages, Azra H Ligon, Fei Dong, David M Meredith,[...]. Acta Neuropathol Commun 2020
19

TRK Fusion Cancers in Children: A Clinical Review and Recommendations for Screening.
Catherine M Albert, Jessica L Davis, Noah Federman, Michela Casanova, Theodore W Laetsch. J Clin Oncol 2019
37

Testing algorithm for identification of patients with TRK fusion cancer.
Frédérique Penault-Llorca, Erin R Rudzinski, Antonia R Sepulveda. J Clin Pathol 2019
68


Targeting tropomyosin receptor kinase for cancer therapy.
Qi Miao, Kun Ma, Dong Chen, Xiaoxing Wu, Sheng Jiang. Eur J Med Chem 2019
5

Antitumor activity of larotrectinib in tumors harboring NTRK gene fusions: a short review on the current evidence.
Biagio Ricciuti, Carlo Genova, Lucio Crinò, Massimo Libra, Giulia Costanza Leonardi. Onco Targets Ther 2019
22



Identifying patients with NTRK fusion cancer.
J P Solomon, R Benayed, J F Hechtman, M Ladanyi. Ann Oncol 2019
61

The rationale for druggability of CCDC6-tyrosine kinase fusions in lung cancer.
Aniello Cerrato, Roberta Visconti, Angela Celetti. Mol Cancer 2018
10

Foretinib Overcomes Entrectinib Resistance Associated with the NTRK1 G667C Mutation in NTRK1 Fusion-Positive Tumor Cells in a Brain Metastasis Model.
Akihiro Nishiyama, Tadaaki Yamada, Kenji Kita, Rong Wang, Sachiko Arai, Koji Fukuda, Azusa Tanimoto, Shinji Takeuchi, Shoichiro Tange, Atsushi Tajima,[...]. Clin Cancer Res 2018
14

Inhibiting TRK Proteins in Clinical Cancer Therapy.
Allison M Lange, Hui-Wen Lo. Cancers (Basel) 2018
69



Comparison of Molecular Testing Modalities for Detection of ROS1 Rearrangements in a Cohort of Positive Patient Samples.
Kurtis D Davies, Anh T Le, Jamie Sheren, Hala Nijmeh, Katherine Gowan, Kenneth L Jones, Marileila Varella-Garcia, Dara L Aisner, Robert C Doebele. J Thorac Oncol 2018
71

Emerging Targeted Therapy for Tumors with NTRK Fusion Proteins.
Ed S Kheder, David S Hong. Clin Cancer Res 2018
56

Clinicopathologic Features of Non-Small-Cell Lung Cancer Harboring an NTRK Gene Fusion.
Anna F Farago, Martin S Taylor, Robert C Doebele, Viola W Zhu, Shivaani Kummar, Alexander I Spira, Theresa A Boyle, Eric B Haura, Maria E Arcila, Ryma Benayed,[...]. JCO Precis Oncol 2018
77

TRK Inhibition: A New Tumor-Agnostic Treatment Strategy.
Shivaani Kummar, Ulrik N Lassen. Target Oncol 2018
43

Targeting MET in Lung Cancer: Will Expectations Finally Be MET?
Alexander Drilon, Federico Cappuzzo, Sai-Hong Ignatius Ou, D Ross Camidge. J Thorac Oncol 2017
161